Nuveen Asset Management, LLC Bristol Myers Squibb CO Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 9,949,721 shares of BMY stock, worth $402 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

9,949,721

Previous 10,705,756 7.06%

Holding current value

$402 Million

Previous $549 Million 1.77%

% of portfolio

0.16%

Previous 0.18%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $36.3 Million - $41.1 Million	-756,035 Reduced 7.06%	9,949,721 $540 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $31.2 Million - $37.3 Million	-644,574 Reduced 5.68%	10,705,756 $549 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $211 Million - $236 Million	-3,653,431 Reduced 24.35%	11,350,330 $659 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $84.7 Million - $94.1 Million	-1,330,078 Reduced 8.14%	15,003,761 $959 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $82.6 Million - $93.7 Million	-1,257,704 Reduced 7.15%	16,333,839 $1.13 Billion

Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $66.4 Million - $78.6 Million	968,998 Added 5.83%	17,591,543 $1.27 Billion
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $112,456 - $66.5 Million	865,053 Added 5.49%	16,622,545 $1.18 Billion
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $162 Million - $178 Million	2,226,874 Added 16.46%	15,757,492 $1.21 Billion
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $25.2 Million - $30.2 Million	410,317 Added 3.13%	13,530,618 $961 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $47.5 Million - $55.3 Million	-884,926 Reduced 6.32%	13,120,301 $818 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $42.8 Million - $50.2 Million	-723,903 Reduced 4.91%	14,005,227 $829 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $20.4 Million - $22.2 Million	328,973 Added 2.28%	14,729,130 $984 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $9.37 Million - $10.5 Million	-157,862 Reduced 1.08%	14,400,157 $909 Million
Q4 2020 May 17, 2021	SELL	$57.74 - $65.43 $11 Million - $12.4 Million	-190,204 Reduced 1.29%	14,558,019 $903 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $89.8 Million - $102 Million	1,555,898 Added 11.79%	14,748,223 $915 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $1.98 Million - $2.2 Million	-34,499 Reduced 0.26%	13,192,325 $795 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $274 Million - $320 Million	-4,992,608 Reduced 27.4%	13,226,824 $778 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $143 Million - $208 Million	-3,091,390 Reduced 14.51%	18,219,432 $1.02 Billion
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $557 Million - $727 Million	11,327,720 Added 113.47%	21,310,822 $1.37 Billion
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $25.1 Million - $29.8 Million	587,982 Added 6.26%	9,983,102 $506 Million
Q2 2019 Aug 15, 2019	BUY	$44.62 - $49.34 $416 Million - $460 Million	9,332,319 Added 14860.14%	9,395,120 $426 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $363,622 - $433,574	8,059 Added 14.72%	62,801 $3 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $8,874 - $11,507	182 Added 0.33%	54,742 $2.85 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $76,990 - $86,838	-1,395 Reduced 2.49%	54,560 $3.39 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $2.07 Million - $2.58 Million	-40,922 Reduced 42.24%	55,955 $3.1 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $9.42 Million - $10.8 Million	-157,239 Reduced 61.88%	96,877 $6.13 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $11.5 Million - $12.5 Million	191,370 Added 304.99%	254,116 $0
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $3.47 Million - $4 Million	62,746	62,746 $4 Million

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Bristol Myers Squibb CO Transaction History